KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $2.4 billion.

  • Pfizer's Dividends Paid - Common fell 6573.19% to $2.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 billion, marking a year-over-year increase of 182.41%. This contributed to the annual value of $9.5 billion for FY2024, which is 286.58% up from last year.
  • Latest data reveals that Pfizer reported Dividends Paid - Common of $2.4 billion as of Q3 2025, which was down 6573.19% from $2.4 billion recorded in Q2 2025.
  • Pfizer's Dividends Paid - Common's 5-year high stood at $7.1 billion during Q3 2024, with a 5-year trough of $2.2 billion in Q2 2021.
  • Its 5-year average for Dividends Paid - Common is $3.2 billion, with a median of $2.3 billion in 2023.
  • As far as peak fluctuations go, Pfizer's Dividends Paid - Common skyrocketed by 20821.09% in 2024, and later tumbled by 6573.19% in 2025.
  • Over the past 5 years, Pfizer's Dividends Paid - Common (Quarter) stood at $6.5 billion in 2021, then rose by 3.03% to $6.7 billion in 2022, then tumbled by 65.64% to $2.3 billion in 2023, then skyrocketed by 208.08% to $7.1 billion in 2024, then plummeted by 65.73% to $2.4 billion in 2025.
  • Its Dividends Paid - Common was $2.4 billion in Q3 2025, compared to $2.4 billion in Q2 2025 and $2.4 billion in Q1 2025.